Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders.

Hall S, Janelidze S, Surova Y, Widner H, Zetterberg H, Hansson O.

Sci Rep. 2018 Sep 5;8(1):13276. doi: 10.1038/s41598-018-31517-z.

2.

Alteration of putaminal fractional anisotropy in Parkinson's disease: a longitudinal diffusion kurtosis imaging study.

Surova Y, Nilsson M, Lampinen B, Lätt J, Hall S, Widner H, van Westen D, Hansson O.

Neuroradiology. 2018 Mar;60(3):247-254. doi: 10.1007/s00234-017-1971-3. Epub 2018 Jan 24.

3.

11 C-PE2I and 18 F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study.

Li W, Lao-Kaim NP, Roussakis AA, Martín-Bastida A, Valle-Guzman N, Paul G, Loane C, Widner H, Politis M, Foltynie T, Barker RA, Piccini P.

Mov Disord. 2018 Jan;33(1):117-127. doi: 10.1002/mds.27183. Epub 2017 Oct 30.

4.

Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease.

Willows T, Dizdar N, Nyholm D, Widner H, Grenholm P, Schmiauke U, Urbom A, Groth K, Larsson J, Permert J, Kjellander S.

J Parkinsons Dis. 2017;7(4):719-728. doi: 10.3233/JPD-161048.

5.

In vivo retention of 18F-AV-1451 in corticobasal syndrome.

Smith R, Schöll M, Widner H, van Westen D, Svenningsson P, Hägerström D, Ohlsson T, Jögi J, Nilsson C, Hansson O.

Neurology. 2017 Aug 22;89(8):845-853. doi: 10.1212/WNL.0000000000004264. Epub 2017 Jul 28.

6.

Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.

Martin-Bastida A, Lao-Kaim NP, Loane C, Politis M, Roussakis AA, Valle-Guzman N, Kefalopoulou Z, Paul-Visse G, Widner H, Xing Y, Schwarz ST, Auer DP, Foltynie T, Barker RA, Piccini P.

Eur J Neurol. 2017 Feb;24(2):357-365. doi: 10.1111/ene.13208. Epub 2016 Dec 16.

7.

A genome-wide association study in multiple system atrophy.

Sailer A, Scholz SW, Nalls MA, Schulte C, Federoff M, Price TR, Lees A, Ross OA, Dickson DW, Mok K, Mencacci NE, Schottlaender L, Chelban V, Ling H, O'Sullivan SS, Wood NW, Traynor BJ, Ferrucci L, Federoff HJ, Mhyre TR, Morris HR, Deuschl G, Quinn N, Widner H, Albanese A, Infante J, Bhatia KP, Poewe W, Oertel W, Höglinger GU, Wüllner U, Goldwurm S, Pellecchia MT, Ferreira J, Tolosa E, Bloem BR, Rascol O, Meissner WG, Hardy JA, Revesz T, Holton JL, Gasser T, Wenning GK, Singleton AB, Houlden H; European Multiple System Atrophy Study Group and the UK Multiple System Atrophy Study Group.

Neurology. 2016 Oct 11;87(15):1591-1598. Epub 2016 Sep 14.

8.

Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease.

Surova Y, Lampinen B, Nilsson M, Lätt J, Hall S, Widner H; Swedish BioFINDER study, van Westen D, Hansson O.

PLoS One. 2016 Jun 30;11(6):e0157755. doi: 10.1371/journal.pone.0157755. eCollection 2016.

9.

Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs.

Pålhagen SE, Sydow O, Johansson A, Nyholm D, Holmberg B, Widner H, Dizdar N, Linder J, Hauge T, Jansson R, Bergmann L, Kjellander S, Marshall TS.

Parkinsonism Relat Disord. 2016 Aug;29:17-23. doi: 10.1016/j.parkreldis.2016.06.002. Epub 2016 Jun 4.

10.

Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain.

Li W, Englund E, Widner H, Mattsson B, van Westen D, Lätt J, Rehncrona S, Brundin P, Björklund A, Lindvall O, Li JY.

Proc Natl Acad Sci U S A. 2016 Jun 7;113(23):6544-9. doi: 10.1073/pnas.1605245113. Epub 2016 May 2.

11.

Aberrant nigral diffusion in Parkinson's disease: A longitudinal diffusion tensor imaging study.

Loane C, Politis M, Kefalopoulou Z, Valle-Guzman N, Paul G, Widner H, Foltynie T, Barker RA, Piccini P.

Mov Disord. 2016 Jul;31(7):1020-6. doi: 10.1002/mds.26606. Epub 2016 Apr 22.

PMID:
27104232
12.

Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease.

Memedi M, Nyholm D, Johansson A, Pålhagen S, Willows T, Widner H, Linder J, Westin J.

IEEE J Biomed Health Inform. 2015 Nov;19(6):1829-34. doi: 10.1109/JBHI.2015.2468088. Epub 2015 Aug 13.

PMID:
26285227
13.

Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy.

Surova Y, Nilsson M, Lätt J, Lampinen B, Lindberg O, Hall S, Widner H, Nilsson C, van Westen D, Hansson O.

Neuroradiology. 2015 Nov;57(11):1079-91. doi: 10.1007/s00234-015-1563-z. Epub 2015 Aug 8.

14.

Memantine and reduced time with dyskinesia in Parkinson's Disease.

Wictorin K, Widner H.

Acta Neurol Scand. 2016 May;133(5):355-60. doi: 10.1111/ane.12468. Epub 2015 Aug 3.

PMID:
26234336
15.

Speech perception in noise for bilingual listeners with normal hearing.

Lucks Mendel L, Widner H.

Int J Audiol. 2016;55(2):126-34. doi: 10.3109/14992027.2015.1061710. Epub 2015 Jul 19.

PMID:
26189557
16.

Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson's disease patients.

Paul G, Zachrisson O, Varrone A, Almqvist P, Jerling M, Lind G, Rehncrona S, Linderoth B, Bjartmarz H, Shafer LL, Coffey R, Svensson M, Mercer KJ, Forsberg A, Halldin C, Svenningsson P, Widner H, Frisén J, Pålhagen S, Haegerstrand A.

J Clin Invest. 2015 Mar 2;125(3):1339-46. doi: 10.1172/JCI79635. Epub 2015 Feb 17.

17.

Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.

Svenningsson P, Rosenblad C, Af Edholm Arvidsson K, Wictorin K, Keywood C, Shankar B, Lowe DA, Björklund A, Widner H.

Brain. 2015 Apr;138(Pt 4):963-73. doi: 10.1093/brain/awu409. Epub 2015 Feb 10.

18.

Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports.

Kefalopoulou Z, Politis M, Piccini P, Mencacci N, Bhatia K, Jahanshahi M, Widner H, Rehncrona S, Brundin P, Björklund A, Lindvall O, Limousin P, Quinn N, Foltynie T.

JAMA Neurol. 2014 Jan;71(1):83-7. doi: 10.1001/jamaneurol.2013.4749.

19.

Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy.

Kaufman E, Hall S, Surova Y, Widner H, Hansson O, Lindqvist D.

PLoS One. 2013 Apr 23;8(4):e62354. doi: 10.1371/journal.pone.0062354. Print 2013.

20.

The natural history of multiple system atrophy: a prospective European cohort study.

Wenning GK, Geser F, Krismer F, Seppi K, Duerr S, Boesch S, Köllensperger M, Goebel G, Pfeiffer KP, Barone P, Pellecchia MT, Quinn NP, Koukouni V, Fowler CJ, Schrag A, Mathias CJ, Giladi N, Gurevich T, Dupont E, Ostergaard K, Nilsson CF, Widner H, Oertel W, Eggert KM, Albanese A, del Sorbo F, Tolosa E, Cardozo A, Deuschl G, Hellriegel H, Klockgether T, Dodel R, Sampaio C, Coelho M, Djaldetti R, Melamed E, Gasser T, Kamm C, Meco G, Colosimo C, Rascol O, Meissner WG, Tison F, Poewe W; European Multiple System Atrophy Study Group.

Lancet Neurol. 2013 Mar;12(3):264-74. doi: 10.1016/S1474-4422(12)70327-7. Epub 2013 Feb 5.

21.

Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease.

Pålhagen SE, Dizdar N, Hauge T, Holmberg B, Jansson R, Linder J, Nyholm D, Sydow O, Wainwright M, Widner H, Johansson A.

Acta Neurol Scand. 2012 Dec;126(6):e29-33. doi: 10.1111/j.1600-0404.2012.01689.x. Epub 2012 Jun 12.

PMID:
22690905
22.

Accuracy and sensitivity of Parkinsonian disorder diagnoses in two Swedish national health registers.

Feldman AL, Johansson AL, Gatz M, Flensburg M, Petzinger GM, Widner H, Lew MF, Pedersen NL, Wirdefeldt K.

Neuroepidemiology. 2012;38(3):186-93. doi: 10.1159/000336356. Epub 2012 Mar 29.

23.

First neuropathological description of a patient with Parkinson's disease and LRRK2 p.N1437H mutation.

Puschmann A, Englund E, Ross OA, Vilariño-Güell C, Lincoln SJ, Kachergus JM, Cobb SA, Törnqvist AL, Rehncrona S, Widner H, Wszolek ZK, Farrer MJ, Nilsson C.

Parkinsonism Relat Disord. 2012 May;18(4):332-8. doi: 10.1016/j.parkreldis.2011.11.019. Epub 2011 Dec 6.

24.

Neuron-specific enolase correlates with other prognostic markers after cardiac arrest.

Cronberg T, Rundgren M, Westhall E, Englund E, Siemund R, Rosén I, Widner H, Friberg H.

Neurology. 2011 Aug 16;77(7):623-30. doi: 10.1212/WNL.0b013e31822a276d. Epub 2011 Jul 20.

PMID:
21775743
25.

Parkinson disease: Poor results for retinal cell transplants in Parkinson disease.

Cenci MA, Widner H.

Nat Rev Neurol. 2011 Jul 19;7(8):424-5. doi: 10.1038/nrneurol.2011.111. No abstract available.

PMID:
21769124
26.

Signs of degeneration in 12-22-year old grafts of mesencephalic dopamine neurons in patients with Parkinson's disease.

Kurowska Z, Englund E, Widner H, Lindvall O, Li JY, Brundin P.

J Parkinsons Dis. 2011;1(1):83-92. doi: 10.3233/JPD-2011-11004.

PMID:
23939259
27.

Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.

Köllensperger M, Geser F, Ndayisaba JP, Boesch S, Seppi K, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Klockgether T, Yekhlef F, Tison F, Daniels C, Deuschl G, Coelho M, Sampaio C, Bozi M, Quinn N, Schrag A, Mathias CJ, Fowler C, Nilsson CF, Widner H, Schimke N, Oertel W, Del Sorbo F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Colosimo C, Meco G, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Rascol O, Kamm C, Gasser T, Siebert U, Poewe W, Wenning GK; EMSA-SG.

Mov Disord. 2010 Nov 15;25(15):2604-12. doi: 10.1002/mds.23192.

PMID:
20922810
28.

Efficacy and safety of the dopaminergic stabilizer Pridopidine (ACR16) in patients with Huntington's disease.

Lundin A, Dietrichs E, Haghighi S, Göller ML, Heiberg A, Loutfi G, Widner H, Wiktorin K, Wiklund L, Svenningsson A, Sonesson C, Waters N, Waters S, Tedroff J.

Clin Neuropharmacol. 2010 Sep-Oct;33(5):260-4. doi: 10.1097/WNF.0b013e3181ebb285.

PMID:
20616707
29.

Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.

Li JY, Englund E, Widner H, Rehncrona S, Björklund A, Lindvall O, Brundin P.

Mov Disord. 2010 Jun 15;25(8):1091-6. doi: 10.1002/mds.23012.

PMID:
20198645
30.

Recommendations on the diagnosis and management of Niemann-Pick disease type C.

NP-C Guidelines Working Group, Wraith JE, Baumgartner MR, Bembi B, Covanis A, Levade T, Mengel E, Pineda M, Sedel F, Topçu M, Vanier MT, Widner H, Wijburg FA, Patterson MC.

Mol Genet Metab. 2009 Sep-Oct;98(1-2):152-65. doi: 10.1016/j.ymgme.2009.06.008. Epub 2009 Jun 14.

PMID:
19647672
31.

A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction.

Puschmann A, Ross OA, Vilariño-Güell C, Lincoln SJ, Kachergus JM, Cobb SA, Lindquist SG, Nielsen JE, Wszolek ZK, Farrer M, Widner H, van Westen D, Hägerström D, Markopoulou K, Chase BA, Nilsson K, Reimer J, Nilsson C.

Parkinsonism Relat Disord. 2009 Nov;15(9):627-32. doi: 10.1016/j.parkreldis.2009.06.007. Epub 2009 Jul 25.

32.

Long-term neurological outcome after cardiac arrest and therapeutic hypothermia.

Cronberg T, Lilja G, Rundgren M, Friberg H, Widner H.

Resuscitation. 2009 Oct;80(10):1119-23. doi: 10.1016/j.resuscitation.2009.06.021. Epub 2009 Jul 23.

PMID:
19631442
33.

Alpha-synuclein multiplications with parkinsonism, dementia or progressive myoclonus?

Puschmann A, Wszolek ZK, Farrer M, Gustafson L, Widner H, Nilsson C.

Parkinsonism Relat Disord. 2009 Jun;15(5):390-2. doi: 10.1016/j.parkreldis.2008.08.002. Epub 2008 Sep 27.

PMID:
18824390
34.

Red flags for multiple system atrophy.

Köllensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, Boesch S, Mueller J, Koukouni V, Quinn N, Pellecchia MT, Barone P, Schimke N, Dodel R, Oertel W, Dupont E, Østergaard K, Daniels C, Deuschl G, Gurevich T, Giladi N, Coelho M, Sampaio C, Nilsson C, Widner H, Sorbo FD, Albanese A, Cardozo A, Tolosa E, Abele M, Klockgether T, Kamm C, Gasser T, Djaldetti R, Colosimo C, Meco G, Schrag A, Poewe W, Wenning GK; European MSA Study Group.

Mov Disord. 2008 Jun 15;23(8):1093-9. doi: 10.1002/mds.21992.

PMID:
18442131
35.

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.

Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Björklund A, Widner H, Revesz T, Lindvall O, Brundin P.

Nat Med. 2008 May;14(5):501-3. doi: 10.1038/nm1746. Epub 2008 Apr 6.

PMID:
18391963
36.

Medication report reduces number of medication errors when elderly patients are discharged from hospital.

Midlöv P, Holmdahl L, Eriksson T, Bergkvist A, Ljungberg B, Widner H, Nerbrand C, Höglund P.

Pharm World Sci. 2008 Jan;30(1):92-8. Epub 2007 Jul 28.

PMID:
17661157
37.

Complete ascertainment of Parkinson disease in the Swedish Twin Registry.

Wirdefeldt K, Gatz M, Bakaysa SL, Fiske A, Flensburg M, Petzinger GM, Widner H, Lew MF, Welsh M, Pedersen NL.

Neurobiol Aging. 2008 Dec;29(12):1765-73. Epub 2007 May 29.

38.

Tracking the neurodegeneration of parkinsonian disorders--a pilot study.

Nilsson C, Markenroth Bloch K, Brockstedt S, Lätt J, Widner H, Larsson EM.

Neuroradiology. 2007 Feb;49(2):111-9. Epub 2007 Jan 3.

PMID:
17200869
39.

Measuring fatigue in Parkinson's disease: a psychometric study of two brief generic fatigue questionnaires.

Hagell P, Höglund A, Reimer J, Eriksson B, Knutsson I, Widner H, Cella D.

J Pain Symptom Manage. 2006 Nov;32(5):420-32.

PMID:
17085268
40.

Fulfilment of patients' goals after thalamic deep brain stimulation: a follow-up study.

Törnqvist AL, Ahlström G, Widner H, Rehncrona S.

Parkinsonism Relat Disord. 2007 Feb;13(1):29-34. Epub 2006 Aug 22.

PMID:
16928465
41.

Health-related quality of life in multiple system atrophy.

Schrag A, Geser F, Stampfer-Kountchev M, Seppi K, Sawires M, Köllensperger M, Scherfler C, Quinn N, Pellecchia MT, Barone P, Del Sorbo F, Albanese A, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Nilsson CF, Widner H, Lindvall O, Giladi N, Gurevich T, Daniels C, Deuschl G, Coelho M, Sampaio C, Abele M, Klockgether T, Schimke N, Eggert KM, Oertel W, Djaldetti R, Colosimo C, Meco G, Poewe W, Wenning GK; European MSA-Study Group.

Mov Disord. 2006 Jun;21(6):809-15.

PMID:
16502399
42.

[Restless legs--common but often missed disease. Successful treatment possibilities are now available].

Ekbom K, Leissner L, Olsson JE, Widner H.

Lakartidningen. 2006 Jan 25-31;103(4):207-11. Review. Swedish. No abstract available.

PMID:
16491552
43.

The European Multiple System Atrophy-Study Group (EMSA-SG).

Geser F, Seppi K, Stampfer-Kountchev M, Köllensperger M, Diem A, Ndayisaba JP, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Dodel R, Klockgether T, Ghorayeb I, Yekhlef F, Tison F, Daniels C, Kopper F, Deuschl G, Coelho M, Ferreira J, Rosa MM, Sampaio C, Bozi M, Schrag A, Hooker J, Kim H, Scaravilli T, Mathias CJ, Fowler C, Wood N, Quinn N, Widner H, Nilsson CF, Lindvall O, Schimke N, Eggert KM, Oertel W, del Sorbo F, Carella F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Meco G, Colosimo C, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Ory F, Rascol O, Kamm C, Buerk K, Maass S, Gasser T, Poewe W, Wenning GK; EMSA-SG.

J Neural Transm (Vienna). 2005 Dec;112(12):1677-86. Epub 2005 Jul 29. Review.

PMID:
16049636
45.

Immune problems in central nervous system cell therapy.

Barker RA, Widner H.

NeuroRx. 2004 Oct;1(4):472-81. Review.

46.

[Therapeutic hypothermia after cardiac arrest. A cold intravenous fluid, a cooling helmet and a cooling blanket efficiently reduce body temperature].

Friberg H, Nielsen N, Karlsson T, Cronberg T, Widner H, Englund E, Ersson A.

Lakartidningen. 2004 Jul 22;101(30-31):2408-11. Swedish.

PMID:
15314936
47.

Intracerebral cytokine profiles in adult rats grafted with neural tissue of different immunological disparity.

Mirza B, Krook H, Andersson P, Larsson LC, Korsgren O, Widner H.

Brain Res Bull. 2004 Mar 15;63(2):105-18.

PMID:
15130699
48.

Activated porcine embryonic brain endothelial cells induce a proliferative human T-lymphocyte response.

Sumitran-Holgersson S, Brevig T, Widner H, Holgersson J.

Cell Transplant. 2003;12(6):637-46.

PMID:
14579932
49.

Induction of operational tolerance to discordant dopaminergic porcine xenografts.

Larsson LC, Corbascio M, Pearson TC, Larsen CP, Ekberg H, Widner H.

Transplantation. 2003 May 15;75(9):1448-54.

PMID:
12792495
50.

Long-term efficacy of thalamic deep brain stimulation for tremor: double-blind assessments.

Rehncrona S, Johnels B, Widner H, Törnqvist AL, Hariz M, Sydow O.

Mov Disord. 2003 Feb;18(2):163-70.

PMID:
12539209

Supplemental Content

Loading ...
Support Center